Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYCS | P99999 | 4/20 | 0.70 |
| ▸ | TOP1 | P11387 | 4/20 | 0.69 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.55 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.48 |
| ▸ | STAT3 | P40763 | 1/20 | 0.47 |
| ▸ | STAT1 | P42224 | 1/20 | 0.47 |
| ▸ | TERT | O14746 | 4/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Zinc Ion SCHEMBL6693551 | 0.97 | TOP1 (0.69) | CYCSTOP1ENPP2ABCG2STAT3 | |
| SCHEMBL6417052 | 0.94 | CYCS (0.73) | CYCSTOP1ENPP2ABCG2TERT | |
| Zinc Ion SCHEMBL3793018 | 0.91 | TOP1 (0.72) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL8994517 | 0.91 | TOP1 (0.72) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL3130597 | 0.91 | TOP1 (0.72) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL11528996 | 0.91 | TOP1 (0.72) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL9273850 | 0.91 | TOP1 (0.72) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL31463072 | 0.91 | TOP1 (0.72) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL2110994 | 0.91 | TOP1 (0.72) | CYCSTOP1ENPP2ABCG2TERT | |
| SCHEMBL3454784 | 0.91 | TOP1 (0.72) | CYCSTOP1ENPP2ABCG2TERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004092185-A1 | LUMINESCENT LANTHANIDE (III) -CHELATED DENDRITIC COMPLEXES HAVING LIGHT-HARVESTING EFFECT AND THEIR SYNTHETIC METHODS | KIM HWAN-KYU (KR) | 2004-10-28 | — | — | WO | disclosed |